Marshall Financial Group (Maryland)’s AstraZeneca AZN Stock Holding History

Marshall Financial Group (Maryland)’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$787K	Buy	+4,153	New	+$781K	0.11%	170

Other funds holding AZN

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

MIF

Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return

ZIC

ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

Marshall Financial Group (Maryland)'s AZN Position: Q2 2026 in Review

Marshall Financial Group (Maryland) opened a new position in AstraZeneca (AZN) in Q2 2026: 4,153 shares worth $787K. The stake represents 0.11% of the portfolio and ranks #170 among its holdings.

443 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Marshall Financial Group (Maryland) held 4,153 shares of AstraZeneca worth $787K as of Q2 2026.
AstraZeneca was a new Marshall Financial Group (Maryland) position in Q2 2026.
AstraZeneca made up 0.11% of Marshall Financial Group (Maryland)'s portfolio in Q2 2026, its #170 holding.
443 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Marshall Financial Group (Maryland)'s 13F filing for Q2 2026, filed 20 Jul 2026.